Breast Implant Patient Preferences Topic Of New FDA Study
Executive Summary
The US agency’s study will look at how the potential cancer risk tied to textured breast implants, as well as other factors, play into how patients decide what type of implants to get.
You may also be interested in...
New Cancer Risks Linked To Breast Implants, FDA Warns
The US FDA has learned of new cancer risks associated with breast implants that differ from cancers the agency has warned about in the past.
FDA: 36 Dead From Breast Implant-Associated Lymphoma Since 2019, Hundreds Sickened
The US FDA reports the numbers on women globally who've died or been sickened by two types of breast implant illnesses.
Joint Mission: FDA And VA Partner On Device Development Initiative
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.